Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Senolytics for Skeletal Health in Older Women
NCT04313634Phase 2Completed
- Start
- Jun 2020
- Primary completion
- Jun 2023
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dasatinib, quercetin, fisetin in osteoporosis. Started Jun 2020; status: completed.
02
Drugs
dasatinibquercetinfisetin
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT04313634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04313634.